华东医药：含利多卡因注射用交联透明质酸钠凝胶注册申请获受理

Core Viewpoint - The company Huadong Medicine (000963) announced that its wholly-owned subsidiary, Xinkelimeixue (Hangzhou) Medical Technology Co., Ltd., has received an acceptance notice from the National Medical Products Administration (NMPA) for its application to register a Class III medical device, the lidocaine injection cross-linked hyaluronic acid gel MaiLi Precise [1] Group 1 - The acceptance notice indicates progress in the regulatory approval process for the medical device [1] - The registered product, MaiLi Precise, is a cross-linked hyaluronic acid gel that includes lidocaine, suggesting a focus on aesthetic and medical applications [1] - This development may enhance the company's product portfolio and market competitiveness in the medical aesthetics sector [1]